Considering the critical crosstalk between obesity, NASH, and HCC, this review will present the connections of IL-1β and IL-18 from obesity-associated NASH with HCC and will discuss approaches to using these cytokines as therapeutic targets against HCC. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.